Neuropathic-like pain symptoms in inflammatory hand osteoarthritis lower quality of life and may not decrease under prednisolone treatment.
Journal
European journal of pain (London, England)
ISSN: 1532-2149
Titre abrégé: Eur J Pain
Pays: England
ID NLM: 9801774
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
revised:
25
05
2022
received:
22
11
2021
accepted:
30
05
2022
pubmed:
8
6
2022
medline:
17
8
2022
entrez:
7
6
2022
Statut:
ppublish
Résumé
Pain is common in hand osteoarthritis (OA) and multiple types may occur. We investigated the prevalence, associated patient characteristics, influence on health-related quality of life (HR-QoL) and response to anti-inflammatory treatment of neuropathic-like pain in inflammatory hand OA. Data were analysed from a 6-week, randomized, double-blind, placebo-controlled trial investigating prednisolone treatment in 92 patients with painful inflammatory hand OA. Neuropathic-like pain was measured with the painDETECT questionnaire. Associations between baseline characteristics and baseline neuropathic-like pain were analysed with ordinal logistic regression, association of baseline neuropathic-like pain symptoms with baseline HR-QoL with linear regression, painDETECT and visual analogue scale (VAS) change from baseline to week 6 and interaction of painDETECT with prednisolone efficacy on VAS pain change from baseline to week 6 with generalized estimating equations (GEE). Of 91 patients (79% female, mean age 64) with complete painDETECT data at baseline, 53% were unlikely to have neuropathic-like pain, 31% were indeterminate and 16% were likely to have neuropathic-like pain. Neuropathic-like pain was associated with female sex, less radiographic damage and more comorbidities. Patients with neuropathic-like pain had lower HR-QoL (PCS-6.5 [95% CI -10.4 to -2.6]) than those without. Neuropathic-like pain symptoms remained under prednisolone treatment and no interaction was seen between painDETECT and prednisolone efficacy on VAS pain. In this study, 16% of inflammatory hand OA patients had neuropathic-like pain. They were more often female, had more comorbidities and had lower QoL than those without. Neuropathic-like pain symptoms remained despite prednisolone treatment and did not seem to affect the outcome of prednisolone treatment. Pain is the dominant symptom in hand OA, with an unclear aetiology. In this study, we found that neuropathic-like pain may play a role in hand OA, that it showed associations with female sex, younger age and more comorbidities and that it lowered health-related quality of life in hand OA. Neuropathic-like pain in hand OA seems resistant to prednisolone therapy but did not seem to interfere with the treatment of inflammatory pain with prednisolone.
Sections du résumé
BACKGROUND
Pain is common in hand osteoarthritis (OA) and multiple types may occur. We investigated the prevalence, associated patient characteristics, influence on health-related quality of life (HR-QoL) and response to anti-inflammatory treatment of neuropathic-like pain in inflammatory hand OA.
METHODS
Data were analysed from a 6-week, randomized, double-blind, placebo-controlled trial investigating prednisolone treatment in 92 patients with painful inflammatory hand OA. Neuropathic-like pain was measured with the painDETECT questionnaire. Associations between baseline characteristics and baseline neuropathic-like pain were analysed with ordinal logistic regression, association of baseline neuropathic-like pain symptoms with baseline HR-QoL with linear regression, painDETECT and visual analogue scale (VAS) change from baseline to week 6 and interaction of painDETECT with prednisolone efficacy on VAS pain change from baseline to week 6 with generalized estimating equations (GEE).
RESULTS
Of 91 patients (79% female, mean age 64) with complete painDETECT data at baseline, 53% were unlikely to have neuropathic-like pain, 31% were indeterminate and 16% were likely to have neuropathic-like pain. Neuropathic-like pain was associated with female sex, less radiographic damage and more comorbidities. Patients with neuropathic-like pain had lower HR-QoL (PCS-6.5 [95% CI -10.4 to -2.6]) than those without. Neuropathic-like pain symptoms remained under prednisolone treatment and no interaction was seen between painDETECT and prednisolone efficacy on VAS pain.
CONCLUSIONS
In this study, 16% of inflammatory hand OA patients had neuropathic-like pain. They were more often female, had more comorbidities and had lower QoL than those without. Neuropathic-like pain symptoms remained despite prednisolone treatment and did not seem to affect the outcome of prednisolone treatment.
SIGNIFICANCE
Pain is the dominant symptom in hand OA, with an unclear aetiology. In this study, we found that neuropathic-like pain may play a role in hand OA, that it showed associations with female sex, younger age and more comorbidities and that it lowered health-related quality of life in hand OA. Neuropathic-like pain in hand OA seems resistant to prednisolone therapy but did not seem to interfere with the treatment of inflammatory pain with prednisolone.
Identifiants
pubmed: 35671123
doi: 10.1002/ejp.1991
pmc: PMC9541664
doi:
Substances chimiques
Prednisolone
9PHQ9Y1OLM
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1691-1701Informations de copyright
© 2022 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation - EFIC®.
Références
Eur J Pain. 2022 Sep;26(8):1691-1701
pubmed: 35671123
Osteoarthritis Cartilage. 2011 Jun;19(6):647-54
pubmed: 21440077
Clin J Pain. 2011 Nov-Dec;27(9):782-9
pubmed: 21642846
Prog Rehabil Med. 2018 Feb 07;3:20180002
pubmed: 32789227
J Clin Epidemiol. 1998 Nov;51(11):1055-68
pubmed: 9817123
Nat Rev Rheumatol. 2018 Nov;14(11):641-656
pubmed: 30305701
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Korean J Pain. 2017 Jan;30(1):51-58
pubmed: 28119771
Arthritis Care Res (Hoboken). 2014 Dec;66(12):1828-35
pubmed: 25047144
Med Care. 2003 May;41(5):582-92
pubmed: 12719681
PLoS One. 2017 Jul 7;12(7):e0180014
pubmed: 28686639
Arthritis Rheum. 2003 Apr 15;49(2):156-63
pubmed: 12687505
Curr Osteoporos Rep. 2018 Oct;16(5):611-616
pubmed: 30155845
Arthritis Rheumatol. 2019 Jul;71(7):1070-1077
pubmed: 30741501
Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589
pubmed: 31278997
Int J Rheumatol. 2012;2012:703138
pubmed: 23209475
Lancet. 2019 Nov 30;394(10213):1993-2001
pubmed: 31727410
Nat Rev Rheumatol. 2011 Nov 22;8(1):22-31
pubmed: 22105244
Arthritis Care Res (Hoboken). 2020 Feb;72(2):149-162
pubmed: 31908149
Arthritis Res Ther. 2015 Sep 03;17:237
pubmed: 26335941
Curr Med Res Opin. 2016 Jun;32(6):1033-57
pubmed: 26907456
Semin Neurol. 2016 Oct;36(5):462-468
pubmed: 27704502
Arthritis Rheumatol. 2020 Jun;72(6):966-971
pubmed: 31904188
Curr Med Res Opin. 2006 Oct;22(10):1911-20
pubmed: 17022849
J Pain Res. 2017 Oct 10;10:2437-2449
pubmed: 29066930
Osteoarthritis Cartilage. 2013 Sep;21(9):1236-42
pubmed: 23973136
Arthritis Rheum. 1990 Nov;33(11):1601-10
pubmed: 2242058
PLoS One. 2015 Dec 31;10(12):e0146117
pubmed: 26720417
Arthritis Rheum. 2009 Sep 15;61(9):1226-34
pubmed: 19714588
Nat Rev Dis Primers. 2017 Feb 16;3:17002
pubmed: 28205574
J Hand Ther. 2020 Jan - Mar;33(1):103-111
pubmed: 30679091